Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy

Lancet. 1987 Mar 7;1(8532):539-41. doi: 10.1016/s0140-6736(87)90178-4.

Abstract

Three hypogammaglobulinaemic patients with non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy were treated with lymphoblastoid alpha-interferon. All showed a striking improvement in serum aminotransferases after the start of each course of treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agammaglobulinemia / therapy
  • Chronic Disease
  • Drug Contamination*
  • Fluid Therapy
  • Hepatitis C / therapy*
  • Hepatitis C / transmission
  • Hepatitis, Viral, Human / therapy*
  • Humans
  • Interferon Type I / therapeutic use*
  • Plasma / microbiology
  • Splenomegaly / therapy
  • Time Factors
  • Transaminases / blood
  • gamma-Globulins / adverse effects*

Substances

  • Interferon Type I
  • gamma-Globulins
  • Transaminases